STAT+: The politics of passing a major FDA funding bill just got complicated
WASHINGTON — For the last six months, Congress seemed to be sailing towards the uncharacteristically…
Category: Congress
Durbin, Collins blast FDA for failure to ban certain synthetic e-cigarettes
WASHINGTON — Two key senators say the FDA “appears to be on the brink of…
STAT+: Here’s what Democrats changed in their latest drug pricing bill
WASHINGTON — Senate Democrats have put final tweaks on their drug pricing proposal, as they…
Democrats tweak their drug pricing plan in last-ditch effort to pass reforms
WASHINGTON — Senate Democrats are vetting a new, tweaked version of a drug pricing package as…
The unlikely crusader who’s winning the fight to lower hospital prices
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Now is not the time for Congress to further cut hospitals’ Medicare payments
As the U.S. slowly emerges from the Covid-19 pandemic, hospitals hope get back to some…
STAT+: New Senate proposal to lower insulin prices would let drugmakers lock in their current profits
WASHINGTON — A new proposal that senators claim would fix insulin pricing would actually allow…
STAT+: Congress is closer than ever to formally authorizing ARPA-H. But the details aren’t as final as they seem
WASHINGTON — It seemed like the debate over President Biden’s new high-stakes science agency, ARPA-H,…
Opinion: Congress: Fund PrEP to end the HIV epidemic
As the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies…
On Covid messaging, Biden is caught between politics and public health
WASHINGTON — When it comes to Covid-19, President Biden is walking a tightrope. The midterm…
Romney accuses White House of ‘patently false’ information about Covid-19 funds
WASHINGTON — Mitt Romney, a prominent Republican senator who spearheaded failed Covid-19 response funding negotiations, on…
The Senate health committee finally marks up its user fee bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
WASHINGTON — Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether…
Opinion: The Access to Rare Indications Act could be a game changer for millions of Americans
The term “medically necessary” is the yardstick by which insurance companies, including Medicare and Medicaid,…
STAT+: The American Medical Association is fighting an otherwise popular bill to require training doctors about opioid use disorder
WASHINGTON — The American Medical Association wants doctors to have more training on treating people…
STAT+: Key Senate committee proposes a council to ensure FDA better coordinates on accelerated approvals
WASHINGTON — The Senate is taking pains to avoid another Aduhelm controversy. In new bipartisan…
California senators advance three bills meant to crack down on health insurers
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Key Senate panel wants to axe in-person requirement for virtual mental health services
WASHINGTON — A bipartisan group of senators working on mental health policy have proposed axing…
A no good, very bad week for the FDA
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
And so, another working week will soon draw to a close. This is, as you…
Listen: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
What happens when the White House runs out of Covid-19 money? Why are kids suddenly…
AstraZeneca’s ambitious vaccine dreams are finally, officially dead
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Take a stand for those who can’t with the Promising Pathway Act
Every five years since 1992, Congress has reauthorized the Food and Drug Administration user fee…
.jpg)
STAT+: AbbVie dramatically boosts its spending on lobbying
WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three…
As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
What happens when the government stops buying Covid-19 vaccines?
WASHINGTON — The federal government has distributed Covid-19 vaccines and treatments for free so far,…
STAT+: Senate FDA legislation will include dietary supplement, cosmetic reforms
WASHINGTON – Senate lawmakers are set to unveil draft legislation as soon as Monday that…
Dr. Oz peddles medical misinformation — but his political rise could still have a silver lining for sound science
WASHINGTON — In his run for the U.S. Senate, Dr. Oz repeatedly reminds audiences that,…
STAT+: Lawmakers wade into a contentious and long-running battle over orphan drug monopolies
Sparked by an unusual, decade-long fight over a rare disease drug, two U.S. lawmakers have…
Pharma showers John Thune with campaign cash
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Flagship Pioneering hires lobbyists, a first among biotech venture firms
WASHINGTON — Flagship Pioneering, the venture capital firm behind Moderna, is getting into the Washington…
STAT+: The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
WASHINGTON — An oversight board tasked with making the National Institutes of Health more efficient…
White House documents detail a looming squeeze on Covid-19 boosters
WASHINGTON — The White House could run out of Covid-19 vaccines if it moves forward…
STAT+: Congress moves toward reforming FDA accelerated approvals, but with pharma-friendly concessions
WASHINGTON — House lawmakers are moving a little closer toward cracking down on drug makers…
The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Five of Congress’ 10 biggest health earmarks went to Missouri clinics and universities
WASHINGTON — Hospitals, health clinics, and medical schools across the country had hoped to cash…
STAT+: Would drugmakers lower their insulin prices if Congress asks nicely?
WASHINGTON — After a yearslong, drawn-out debate over how to best lower patients’ prescription drug…
The doctor who is trying to bring back surprise billing
If Daniel Haller gets his way, surprise medical bills will be back in full force….
.jpg)
STAT+: Manchin won’t support new health policy unless Congress rolls back Trump tax cuts
WASHINGTON — Sen. Joe Manchin, a moderate Democrat who will determine how much domestic policy…
STAT+: Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies
WASHINGTON — The libertarian think tank behind the federal “right-to-try” law is back at it…
White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
WASHINGTON — It was a striking visual for the television cameras. White House Press Secretary…
Opinion: It’s time for Congress to stop blocking mitochondrial replacement therapy
Australia has become the second country in the world to explicitly authorize and regulate mitochondrial…
Biogen’s head-scratching new lobbyist hire
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
STAT+: New bipartisan insulin policy aims to entice drugmakers to lower prices
WASHINGTON — A bipartisan group of four key lawmakers unveiled a long-shot policy that aims…
STAT+: Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules
WASHINGTON – A bipartisan duo of senators is done waiting for the Food and Drug…
Biden administration ramps up long Covid research efforts following criticism
WASHINGTON — The Biden administration on Tuesday announced plans to ramp up research into long…
Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy
The pressure on Medicare just keeps ramping up Medicare is set to decide this month…
Opinion: Home care instead of hospital care: Congress should extend a crucial waiver
Hospitals can be places of healing and, at times, harm, particularly for older adults with…
Senate nears $10 billion deal to buy Covid vaccines, therapeutics
WASHINGTON — Top Senate negotiators are working to reach a deal to provide the Biden…
STAT+: Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist
WASHINGTON — President Biden’s “moonshot” biomedical research agency will be housed within the National Institutes…